JP2014533285A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533285A5
JP2014533285A5 JP2014541391A JP2014541391A JP2014533285A5 JP 2014533285 A5 JP2014533285 A5 JP 2014533285A5 JP 2014541391 A JP2014541391 A JP 2014541391A JP 2014541391 A JP2014541391 A JP 2014541391A JP 2014533285 A5 JP2014533285 A5 JP 2014533285A5
Authority
JP
Japan
Prior art keywords
item
degrees
crystalline polymorph
crystalline
ray powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014541391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533285A (ja
JP6078076B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/064729 external-priority patent/WO2013071272A1/en
Publication of JP2014533285A publication Critical patent/JP2014533285A/ja
Publication of JP2014533285A5 publication Critical patent/JP2014533285A5/ja
Application granted granted Critical
Publication of JP6078076B2 publication Critical patent/JP6078076B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014541391A 2011-11-11 2012-11-12 キナーゼ阻害剤多形体 Active JP6078076B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161558962P 2011-11-11 2011-11-11
US61/558,962 2011-11-11
PCT/US2012/064729 WO2013071272A1 (en) 2011-11-11 2012-11-12 Kinase inhibitor polymorphs

Publications (3)

Publication Number Publication Date
JP2014533285A JP2014533285A (ja) 2014-12-11
JP2014533285A5 true JP2014533285A5 (enExample) 2015-12-10
JP6078076B2 JP6078076B2 (ja) 2017-02-08

Family

ID=48290672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014541391A Active JP6078076B2 (ja) 2011-11-11 2012-11-12 キナーゼ阻害剤多形体

Country Status (5)

Country Link
US (1) US9403820B2 (enExample)
EP (1) EP2776428A4 (enExample)
JP (1) JP6078076B2 (enExample)
HK (1) HK1201271A1 (enExample)
WO (1) WO2013071272A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060403A2 (en) 2003-01-06 2004-07-22 Angiochem Inc. Aprotinin and anglos as carriers across the blood-brain barrier
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
CA2721019C (en) 2008-04-18 2015-09-15 Angiochem Inc. Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
MX2011004017A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de agonistas glp-1 y usos de los mismos.
WO2010043049A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Etoposide and doxorubicin conjugates for drug delivery
US9914754B2 (en) 2008-12-05 2018-03-13 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
CA2747220A1 (en) 2008-12-17 2010-06-24 Richard Beliveau Membrane type-1 matrix metalloprotein inhibitors and uses thereof
CN102510759A (zh) 2009-04-20 2012-06-20 安吉奥开米公司 利用与血管肽-2类似物结合的抗癌剂治疗卵巢癌
WO2011000095A1 (en) 2009-07-02 2011-01-06 Angiochem Inc. Multimeric peptide conjugates and uses thereof
EP2792360A1 (en) 2013-04-18 2014-10-22 IP Gesellschaft für Management mbH (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV
EP3052493A4 (en) * 2013-10-03 2017-06-14 Millennium Pharmaceuticals, Inc. Enhanced treatment regimens using pi3k inhibitors
WO2016205367A1 (en) 2015-06-15 2016-12-22 Angiochem Inc. Methods for the treatment of leptomeningeal carcinomatosis
JP2018039755A (ja) * 2016-09-08 2018-03-15 大塚化学株式会社 ナトリウム2α−メチル−2β−(1,2,3−トリアゾール−1−イル)−メチルペナム−3α−カルボン酸1,1−ジオキシド一水和物結晶の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE10050663A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
EP1530570A2 (en) * 2003-06-03 2005-05-18 Teva Pharmaceutical Industries Limited CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF
EP1591625A1 (en) * 2004-04-30 2005-11-02 ALSTOM Technology Ltd Gas turbine blade shroud
CA2623374A1 (en) * 2005-09-30 2007-04-05 Astrazeneca Ab Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
KR101660050B1 (ko) * 2008-01-04 2016-09-26 인텔리카인, 엘엘씨 특정 화학 물질, 조성물 및 방법
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
US8476282B2 (en) * 2008-11-03 2013-07-02 Intellikine Llc Benzoxazole kinase inhibitors and methods of use
ES2709108T3 (es) 2009-08-17 2019-04-15 Intellikine Llc Compuestos heterocíclicos y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2014533285A5 (enExample)
TWI513691B (zh) 製備苯并咪唑衍生物之方法
JP6851454B2 (ja) キラルジペプチジルペプチダーゼ−iv阻害剤の製造方法
RU2020128323A (ru) Фенфлураминовые композиции и способы их получения
JP2017503843A (ja) N−[(3−アミノオキセタン−3−イル)メチル]−2−(1,1−ジオキソ−3,5−ジヒドロ−1,4−ベンゾチアゼピン−4−イル)−6−メチル−キナゾリン−4−アミンの製造のための方法
WO2011161690A1 (en) Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof
JP2014507414A5 (enExample)
WO2013121234A1 (en) Process for the preparation of dronedarone by oxidation of a sulphenyl group
RU2011116926A (ru) Безводная и гидратная формы ранелата стронция
JP2018536640A5 (enExample)
JP2009531353A5 (enExample)
KR20140059162A (ko) 페메트렉세드 염의 제조 방법
CN104829590B (zh) 一种纯化曲格列汀的方法
WO2013124748A4 (en) Novel polymorphs of azilsartan medoxomil potassium
JP6533798B2 (ja) ジヒドロイソオキサゾール誘導体の製造方法
JP6228210B2 (ja) フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法
KR102627711B1 (ko) 벤즈옥사졸 화합물의 제조 방법
CN102863341A (zh) 一种(1r,2s)-2-芳基环丙胺衍生物的化学合成方法
JP4130822B2 (ja) スクラレオリドの前駆体の光学分割法
CN108976228A (zh) 一种7-氮杂吲哚的制备方法
CN111801310A (zh) 用于生产春烯的方法
CN102786422B (zh) 一种制备甲磺酸雷沙吉兰的方法
KR101374939B1 (ko) 이토프라이드 염산염 제조에 사용되는 신규 중간체염, 이의 제조방법 및 이를 이용한 이토프라이드 염산염의 제조방법
CN109563063B (zh) 通过2-(2-重氮-6取代的苯基)乙醇盐的环化而制备4-取代的2,3-二氢-1-苯并呋喃衍生物的方法
WO2012172563A3 (en) Novel polymorphs of fosamprenavir calcium